Modern tactics of treatment of tumor pericarditis

Abstract

Pericarditis in cancer patients occures in the late stage of the disease and in 95% of cases is caused by metastases of lung, breast, gastrointestinal cancer and hemoblastosis. Malignant exudate in the pericardial cavity in half cases leads to tamponade of the heart and death of the patient. The actual goal in modern oncology is to find the most effective and low-toxic treatment of pericardial carcinomatosis and tumor pericarditis. One of the effective methods of treating of this category of patients is intrapericardial immunotherapy with IL-2.